| Tag | Content |
|---|
EnhancerAtlas ID | HS105-04309 | Organism | Homo sapiens | Tissue/cell | IMR90 | Coordinate | chr1:110852080-110853360 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_56545 | chr1:110848453-110856332 | u87 |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH01I110307 | chr1 | 110850061 | 110853227 |
| Enhancer Sequence | ACTACTTTAA GTTAATGCTA GGCATTCTCC TGGTGACCCT GTGAATACTG AGCTATTTTC 60
CTGCTCACAG TGGGGATAGG CAACCAGAGC ATCTGGTTTT CCCTGAAAAT GTCTACATTT 120
CCACCAAAAT CTGGCCAGTC TGCATGTGAT AAAGGTAGGA GGATGTTGTC TACCCTTGCT 180
ACAAGGTAAT AGGAGGACAC TGGGAGTTGG CATCTTGATG TAATAAACAC AGGATTCGAA 240
GATAGATAGA CATGGGTTCA AATCTCAACC CCAAGCCTTG GAAGCTGGGT GACCCTGCAT 300
GAGGCACTTC TGAGTGGCCC TTGCTTTTCT GTCTCTAAAC ACGGATGATC ATAATCATAC 360
CAGTCTCCAC TGACTCCAGA CAGTGGTCAT TAGATCCAAT GAGTCAACAC ATGGGAGTAC 420
ACTTTACAGA GTCAGTTATA ACCAGGCATT AGCTGTCAAA TGAATGAGTC CGGTATCTAG 480
GAGAGTTCAC TGCCTGAGGA AGGAAATCCA ACCAATCCCC TGCCTGAGAG CCGAGAGCAG 540
CCAGCTCTAA GGCACCTCCT GGAAGATCTT GCAGCCCTCT GGCACTGAGT TCTTTCTTCT 600
CCAACTTCCT ACCCCCACAT GTTTATAGTC CACACCACAT CTAGTTCTCA CAGTTCAGAA 660
AGTCCTCCAA GCCAGCCCAT CTGAATCCTT TAATGACCTG CTCCTTCCCT GCTTGCTTTC 720
CTTTGCAGAG CCTCCTTCTA TCAATACTTT CCCCCTCACA TGGAATCCAT CCTCACACAG 780
GCCTTTCAGG AGGAAACTTC CCCTGGGCCC CTGACCAGTG TTTCTTTTCA GAGCTTCATC 840
ATTTCCCAGG TGGCTGAGGT TGTAGATTTC AAAGCAAGGC CACAGAACGT AAGCTCCGGG 900
CTGGTTTTCA CTGCTTCTGC CAGCCCTGCT GCTTACCCTC ACACGTCCCT GAAAAGCTTT 960
GGCTGGAACC AGATGCCAAT AGGCTAAGGT CCCTGTTGCC TGGCCCTCCA CAGCATCCAA 1020
ACCAGCAAAC CAGGGGCTTC CCTGGGGCCG AGTGACCTTC TCTGGGAAGT AGGCCAGAGC 1080
TCAGCAAAGT GCTGCCTCTT CAGCCACTGT GACTGTGTGA CGCCTGGGCT GAATCCCAAA 1140
GAACGAGGGC CCAGCTCTGC GGCTGAGAAT CTCAGTAGGG GCAGGGCTAC AGGGACCTCC 1200
ATGGTCAGCA AGCTCAACCT TGTCATTGTC CAGAGGAGGA TACTAAGGCC CAAAGAGGCT 1260
TGGCAATGTG GATAAGGTAG 1280
|
| |
|
|
|
